China Medical gains Korean approval for anticancer HIFU (highintensity focused ultrasound) system:
This article was originally published in Clinica
Executive Summary
The highintensity focused ultrasound (HIFU) tumour therapy system developed by Beijing-based China Medical Technologies has received official approval from the Korean FDA. The device is now approved to treat liver and pancreatic cancers and uterine fibroids. The firm received conditional approval to start US-based human trials of the device from the US FDA in July. Cancer is the leading cause of death in Korea.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.